Aytu BioPharma, Inc. (AYTU) vs Bionano Genomics, Inc. (BNGO)
A side-by-side comparison of Aytu BioPharma, Inc. and Bionano Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AYTU
Aytu BioPharma, Inc.
$2.09HealthcareDelayed quote: Oct 6, 2026, 10:13 AM EDT
BNGO
Bionano Genomics, Inc.
$1.46HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT
Total return — AYTU vs BNGO
growth of $100 · dividends reinvested · last 8yAYTU -99.8% (-53.3%/yr)BNGO -100.0% (-62.5%/yr)AYTU compounded faster over this window
Log scale — wide-divergence pair
AYTU BNGO
AYTU vs BNGO: by the numbers
- •AYTU is the larger company ($22M vs $17M market cap).
- •Both run net losses; AYTU's is the smaller (-24.76% vs -106.58% net margin).
- •BNGO grew revenue faster over the past five years (17.97% vs -2.59% CAGR).
Metrics side by side
Valuation
| Metric | AYTU | BNGO |
|---|---|---|
| P/S ratio | 0.39 | 0.56 |
| P/B ratio | 0.64 | 0.53 |
| FCF yield | 14.50% | N/A |
Profitability
| Metric | AYTU | BNGO |
|---|---|---|
| Gross margin | 63.95% | 21.95% |
| Operating margin | -14.44% | -116.95% |
| Net margin | -24.76% | -106.58% |
| ROE | -40.40% | -101.76% |
| ROIC | -14.21% | -85.72% |
Growth (annualized)
| Metric | AYTU | BNGO |
|---|---|---|
| Revenue CAGR (5Y) | -2.59% | 17.97% |
| Total return CAGR (5Y) | -48.14% | -78.37% |
Frequently asked
- Which has grown faster, AYTU or BNGO?
- Over the past five years, BNGO grew revenue faster — AYTU at a -2.59% CAGR versus BNGO at 17.97%.
- How have AYTU and BNGO total returns compared?
- Over the past 5 years, AYTU delivered -48.14% and BNGO delivered -78.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aytu BioPharma ROEBionano Genomics ROEAytu BioPharma operating marginBionano Genomics operating marginAytu BioPharma revenue growthBionano Genomics revenue growthAytu BioPharma free cash flowBionano Genomics free cash flow
Aytu BioPharma & Bionano Genomics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.